It could be habit forming: Drugs of abuse and striatal synaptic plasticity

Trends in Neurosciences

Volumn 26, Issue 4, 2003, Pages 184-192

  Gerdeman, Gregory L ^a   Partridge, John G ^b   Lupica, Carl R ^c   Lovinger, David M ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; DOPAMINE; NICOTINIC RECEPTOR;

ASSOCIATION CORTEX; BEHAVIOR; BRAIN FUNCTION; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG USE; HUMAN; LIMBIC SYSTEM; NERVE CELL PLASTICITY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SENSORIMOTOR CORTEX; SIGNAL PROCESSING; STRIATE CORTEX;

EID: 0037383352     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(03)00065-1     Document Type: Review

References (89)

1. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2:2001;119-128.
2. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
3. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2:2001;695-703.
4. Everitt B.J., Wolf M.E. Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 22:2002;3312-3320.
5. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 24:2001;97-129.
6. Albin R.L., et al. The functional anatomy of disorders of the basal ganglia. Trends Neurosci. 18:1995;63-64.
7. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci. 13:1990;254-258.
8. Nicola S.M., et al. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci. 23:2000;185-215.
9. Calabresi P., et al. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19:1996;19-24.
10. Pennartz C.M., et al. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42:1994;719-761.
11. Haber S.N., et al. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 20:2000;2369-2382.
12. 2 dopamine receptors. Neuroscience. 95:2000;1043-1048.
13. Centonze D., et al. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology. 26:2002;164-175.
14. 2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J. Neurosci. 20:2000;RC69.
15. Nicola S.M., Malenka R.C. Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum. J. Neurophysiol. 79:1998;1768-1776.
16. 1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J. Neurosci. 17:1997;5271-5280.
17. Carlezon W.A. Jr, Wise R.A. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci. 16:1996;3112-3122.
18. Hoffman A.F., Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol. 85:2001;72-83.
19. Hotsenpiller G., et al. Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure. Eur. J. Neurosci. 14:2001;1843-1855.
20. McFarland K., Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 21:2001;8655-8663.
21. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.). 151:2000;99-120.
22. Calabresi P., et al. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci. 12:1992;4224-4233.
23. Reynolds J.N., et al. A cellular mechanism of reward-related learning. Nature. 413:2001;67-70.
24. Charpier S., et al. In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex. Neuroscience. 91:1999;1209-1222.
25. Spencer J.P., Murphy K.P. Bi-directional changes in synaptic plasticity induced at corticostriatal synapses in vitro. Exp. Brain Res. 135:2000;497-503.
26. Dos Santos Villar F., Walsh J.P. Modulation of long term synaptic plasticity at excitatory striatal synapses. Neuroscience. 90:1999;1031-1041.
27. Tang K., et al. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1255-1260.
28. Choi S., Lovinger D.M. Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc. Natl. Acad. Sci. U. S. A. 94:1997;2665-2670.
29. Kerr J.N., Wickens J.R. Dopamine D1/D5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J. Neurophysiol. 85:2001;117-124.
30. Reynolds J.N., Wickens J.R. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw. 15:2002;507-521.
31. Calabresi P., et al. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J. Neurosci. 20:2000;8443-8451.
32. Centonze D., et al. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur. J. Neurosci. 13:2001;1071-1077.
33. Risinger F.O., et al. Motivational effects of ethanol in DARPP-32 knock-out mice. J. Neurosci. 21:2001;340-348.
34. Mazzucchelli C., et al. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron. 34:2002;807-820.
35. Calabresi P., et al. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J. Neurosci. 19:1999;2489-2499.
36. Robbe D., et al. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8384-8388.
37. Kombian S.B., Malenka R.C. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens. Nature. 368:1994;242-246.
38. Thomas M.J., et al. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci. 4:2001;1217-1223.
39. Choi S., Lovinger D.M. Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression. J. Neurosci. 17:1997;8613-8620.
40. Calabresi P., et al. Post-receptor mechanisms underlying striatal long-term depression. J. Neurosci. 14:1994;4871-4881.
41. Gerdeman G.L., et al. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5:2002;446-451.
42. Gerdeman G., Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85:2001;468-471.
43. Szabo B., et al. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience. 85:1998;395-403.
44. Robbe D., et al. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21:2001;109-116.
45. Pistis M., et al. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur. J. Neurosci. 15:2002;1795-1802.
46. Carlson G., et al. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 5:2002;723-724.
47. Giuffrida A., et al. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2:1999;358-363.
48. Di Marzo V., et al. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
49. Ohno-Shosaku T., et al. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur. J. Neurosci. 15:2002;953-961.
50. Maldonado R., Rodriguez de Fonseca F. Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci. 22:2002;3326-3331.
51. Partridge J.G., et al. Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression. J. Neurosci. 22:2002;2541-2549.
52. Wonnacott S., et al. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur. J. Pharmacol. 393:2000;51-58.
53. Zhou F.M., et al. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4:2001;1224-1229.
54. Calabresi P., et al. Acetylcholine-mediated modulation of striatal function. Trends Neurosci. 23:2000;120-126.
55. Suzuki T., et al. Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons. J. Neurosci. 21:2001;6492-6501.
56. Partridge J.G., et al. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J. Neurophysiol. 84:2000;1422-1429.
57. Jones S., et al. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J. Neurosci. 20:2000;5575-5580.
58. Giorgetti M., et al. Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats. J. Neurosci. 21:2001;6362-6369.
59. Mansvelder H.D., McGehee D.S. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron. 27:2000;349-357.
60. Ungless M.A., et al. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 411:2001;583-587.
61. Melis M., et al. Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J. Neurosci. 22:2002;2074-2082.
62. Mansvelder H.D., et al. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron. 33:2002;905-919.
63. Wu X., French E.D. Effects of chronic Δ9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment. Neuropharmacology. 39:2000;391-398.
64. Graybiel A.M., Rauch S.L. Toward a neurobiology of obsessive-compulsive disorder. Neuron. 28:2000;343-347.
65. Jog M.S., et al. Building neural representations of habits. Science. 286:1999;1745-1749.
66. Packard M.G., Knowlton B.J. Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci. 25:2002;563-593.
67. Schultz W. Getting formal with dopamine and reward. Neuron. 36:2002;241-263.
68. Tremblay L., et al. Modifications of reward expectation-related neuronal activity during learning in primate striatum. J. Neurophysiol. 80:1998;964-977.
69. Nishioku T., et al. Expression of long-term potentiation of the striatum in methamphetamine-sensitized rats. Neurosci. Lett. 268:1999;81-84.
70. Ito R., et al. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 22:2002;6247-6253.
71. Letchworth S.R., et al. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 21:2001;2799-2807.
72. Williams J.T., et al. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81:2001;299-343.
73. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex. 10:2000;318-325.
74. Trantham H., et al. Repeated cocaine administration alters the electrophysiological properties of prefrontal cortical neurons. Neuroscience. 113:2002;749-753.
75. Childress A.R., et al. Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry. 156:1999;11-18.
76. 2+ conductance. J. Neurosci. 17:1997;3334-3342.
77. Gubellini P., et al. Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology. 40:2001;839-846.
78. Sung K.W., et al. Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J. Neurophysiol. 86:2001;2405-2412.
79. Huang C.C., et al. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol. 532:2001;731-748.
80. Jiang Z.G., North R.A. Pre- and postsynaptic inhibition by opioids in rat striatum. J. Neurosci. 12:1992;356-361.
81. Mishkin M., et al. McGaugh J.L., Weinberger N.M., et al. Neurobiology of Human Learning and Memory. 1984;65-87 Guildford.
82. Fernandez-Ruiz J., et al. Visual habit formation in monkeys with neurotoxic lesions of the ventrocaudal neostriatum. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4196-4201.
83. White N.M., McDonald R.J. Multiple parallel memory systems in the brain of the rat. Neurobiol. Learn. Mem. 77:2002;125-184.
84. Knowlton B.J., et al. A neostriatal habit learning system in humans. Science. 273:1996;1399-1402.
85. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat. Neurosci. 3:2000;377-383.
86. Graybiel A.M., et al. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci. 23:2000;S71-S77.
87. Herkenham M., et al. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547:1991;267-274.
88. 2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J. Neurosci. 22:2002;6218-6227.
89. Saka E., et al. Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation. Proc. Natl. Acad. Sci. U. S. A. 99:2002;9004-9009.